With the increasing number of joint infections following surgery there is a critical need for a solution to provide a totally safe aseptic environment in which to perform these surgeries. Genetoo, led by Christopher Whitman, is a promising startup able to revolutionize the healthcare system by meeting the need for a clean, aseptic environment using a technology that was widely used by NASA for space missions.

The secret to Genetoo’s unique technology is that it the topological modifications through chemical coatings and/or laser ablation to provide a surface free of contamination from harmful viruses, bacteria or other pathogens. The ability to repel bacteria and inhibit contact with microorganisms becomes even more critical when a prosthetic is implanted within the human body. The increase of Prosthetic Joint Infection (PJI) is attributed in part to not fully aseptic surgical environments or implants touching the skin or clothes of medical personnel or patients. To combat the rising level of post-surgery infections, Genetoo offers an innovative treatment that allows implantable, internal devices to fully repel bacteria.

Genetoo’s technology could be a ‘game-changer’ as the surgical implant market is a multi-billion dollar industry and growing rapidly given that the number of implant operations is doubling every 10 years. Genetoo’s unique technology has already been successfully demonstrated as a proof of concept and is ready for use in healthcare facilities both in the United States and across the world. One of the major causes in the rise of medical costs is the increase of preventable post-surgical infections that require expensive drugs to treat and, on occasion, could result in a patient’s death. In Christopher Whitman’s vision, no patient should die or face serious health adversity over a fairly trivial operation.

As humans live longer and more active lives due to better diet and medical care, the rise of prosthetic implant surgeries will continue for the foreseeable future. Genetoo’s unique technology aims to revolutionize the healthcare system by improving surgical outcomes, shorting patient recovery time and providing significant medical cost savings.